Vitamin D concentrations and COVID-19 infection in UK Biobank. Issue 4 (July 2020)

• Record Type: Journal Article
• Authors: Hastie, Claire E.; Mackay, Daniel F.; Ho, Frederick; Celis-Morales, Carlos A.; Katikireddi, Srinivasa Vittal; Niedzwiedz, Claire L.; Jani, Bhautesh D.; Welsh, Paul; Mair, Frances S.; Gray, Stuart R.; O'Donnell, Catherine A.; Gill, Jason MR.; Sattar, Naveed; Pell, Jill P.
• Is Part Of: Diabetes & metabolic syndrome. Volume 14:Issue 4(2020)
• Page Start: 561
• Page End: 565
• Publication Date: 2020-07
• Subjects: COVID-19 -- Vitamin D -- Ethnicity; Diabetes -- Periodicals; Metabolism -- Disorders -- Periodicals; Diabetes Mellitus -- Periodicals; Metabolic Diseases -- Periodicals; Diabète -- Périodiques; Métabolisme, Troubles du -- Périodiques; Endocrinologie -- Périodiques; Diabète -- Physiopathologie -- Périodiques; Diabetes; Metabolism -- Disorders; Electronic journals; Periodicals; 616.462
• DOI: 10.1016/j.dsx.2020.04.050
• Languages: English
• ISSNs: 1871-4021

Abstract

Abstract: Background and aims: COVID-19 and low levels of vitamin D appear to disproportionately affect black and minority ethnic individuals. We aimed to establish whether blood 25-hydroxyvitamin D (25(OH)D) concentration was associated with COVID-19 risk, and whether it explained the higher incidence of COVID-19 in black and South Asian people. Methods: UK Biobank recruited 502, 624 participants aged 37–73 years between 2006 and 2010. Baseline exposure data, including 25(OH)D concentration and ethnicity, were linked to COVID-19 test results. Univariable and multivariable logistic regression analyses were performed for the association between 25(OH)D and confirmed COVID-19, and the association between ethnicity and both 25(OH)D and COVID-19. Results: Complete data were available for 348, 598 UK Biobank participants. Of these, 449 had confirmed COVID-19 infection. Vitamin D was associated with COVID-19 infection univariably (OR = 0.99; 95% CI 0.99–0.999; p = 0.013), but not after adjustment for confounders (OR = 1.00; 95% CI = 0.998–1.01; p = 0.208). Ethnicity was associated with COVID-19 infection univariably (blacks versus whites OR = 5.32, 95% CI = 3.68–7.70, p -value<0.001; South Asians versus whites OR = 2.65, 95% CI = 1.65–4.25, p -value<0.001). Adjustment for 25(OH)D concentration made little difference to the magnitude of the association. Conclusions: Our findings do not support a potential link between vitamin D concentrations and risk of COVID-19 infection, nor that vitamin D concentration may explain ethnic differences in COVID-19 infection. Highlights: There is an urgent need to understand risk factors for contracting COVID-19 infection and for poorer prognosis thereafter. COVID-19 appears to disproportionately affects black and minority ethnic individuals. The underlying mechanism is unknown. One potential mediator could be their higher prevalence of apparent vitamin D deficiency. We explored whether blood 25 hydroxyvitamin D (25(OH)D) concentration was associated with COVID-19 risk. We found no evidence that (25(OH)D) explains susceptibility to COVID-19 infection, either overall or between ethnic groups.